Comparison of BAP65, DECAF, PEARL, and MEWS Scores in Predicting Respiratory Support Need in Hospitalized Exacerbation of Chronic Obstructive Lung Disease Patients

Abstract Objective: Prognostic models aid clinical practice with decision-making on treatment and hospitalization in exacerbation of chronic obstructive lung disease (ECOPD). Although there are many studies with prognostic models, diagnostic accuracy is variable within and between models. Subjects a...

Full description

Saved in:
Bibliographic Details
Published inMedical principles and practice Vol. 33; no. 4; pp. 355 - 363
Main Authors Acet-Öztürk, Nilüfer Aylin, Aydin-Güçlü, Özge, Yildiz, Merve Nur, Demirdöğen, Ezgi, Görek Dilektaşli, Aslı, Coşkun, Funda, Uzaslan, Esra, Ursavaş, Ahmet, Karadağ, Mehmet
Format Journal Article
LanguageEnglish
Published Basel, Switzerland S. Karger AG 16.04.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Objective: Prognostic models aid clinical practice with decision-making on treatment and hospitalization in exacerbation of chronic obstructive lung disease (ECOPD). Although there are many studies with prognostic models, diagnostic accuracy is variable within and between models. Subjects and Methods: We compared the prognostic performance of the BAP65 score, DECAF score, PEARL score, and modified early warning score (MEWS) in hospitalized patients with ECOPD, to estimate ventilatory support need. Results: This cross-sectional study consisted of 139 patients. Patients in need of noninvasive or invasive mechanical ventilation support are grouped as ventilatory support groups (n = 54). Comparison between receiver operating characteristic curves revealed that the DECAF score is significantly superior to the PEARL score (p = 0.04) in discriminating patients in need of ventilatory support. DECAF score with a cutoff value of 1 presented the highest sensitivity and BAP65 score with a cutoff value of 2 presented the highest specificity in predicting ventilatory support need. Multivariable analysis revealed that gender played a significant role in COPD exacerbation outcome, and arterial pCO2 and RDW measurements were also predictors of ventilatory support need. Within severity indexes, only the DECAF score was independently associated with the outcome. One-point increase in DECAF score created a 1.43 times higher risk of ventilatory support need. All severity indexes showed a correlation with age, comorbidity index, and dyspnea. BAP65 and DECAF scores also showed a correlation with length of stay. Conclusion: Objective and practical classifications are needed by clinicians to assess prognosis and initiate treatment accordingly. DECAF score is a strong candidate among severity indexes. Highlights of the StudyObjective and practical classifications are needed by clinicians in order to assess prognosis and initiate treatment accordingly in exacerbation of chronic obstructive lung disease.DECAF score with a cutoff value of 1 presented the highest sensitivity and BAP65 score with a cutoff value of 2 presented the highest specificity in predicting the need for ventilatory support.One-point increase in DECAF score created a 1.43 times higher risk of need for ventilatory support.
AbstractList Prognostic models aid clinical practice with decision-making on treatment and hospitalization in exacerbation of chronic obstructive lung disease (ECOPD). Although there are many studies with prognostic models, diagnostic accuracy is variable within and between models.OBJECTIVEPrognostic models aid clinical practice with decision-making on treatment and hospitalization in exacerbation of chronic obstructive lung disease (ECOPD). Although there are many studies with prognostic models, diagnostic accuracy is variable within and between models.We compared the prognostic performance of the BAP65 score, DECAF score, PEARL score, and modified early warning score (MEWS) in hospitalized patients with ECOPD, to estimate ventilatory support need.SUBJECTS AND METHODSWe compared the prognostic performance of the BAP65 score, DECAF score, PEARL score, and modified early warning score (MEWS) in hospitalized patients with ECOPD, to estimate ventilatory support need.This cross-sectional study consisted of 139 patients. Patients in need of noninvasive or invasive mechanical ventilation support are grouped as ventilatory support groups (n = 54). Comparison between receiver operating characteristic curves revealed that the DECAF score is significantly superior to the PEARL score (p = 0.04) in discriminating patients in need of ventilatory support. DECAF score with a cutoff value of 1 presented the highest sensitivity and BAP65 score with a cutoff value of 2 presented the highest specificity in predicting ventilatory support need. Multivariable analysis revealed that gender played a significant role in COPD exacerbation outcome, and arterial pCO2 and RDW measurements were also predictors of ventilatory support need. Within severity indexes, only the DECAF score was independently associated with the outcome. One-point increase in DECAF score created a 1.43 times higher risk of ventilatory support need. All severity indexes showed a correlation with age, comorbidity index, and dyspnea. BAP65 and DECAF scores also showed a correlation with length of stay.RESULTSThis cross-sectional study consisted of 139 patients. Patients in need of noninvasive or invasive mechanical ventilation support are grouped as ventilatory support groups (n = 54). Comparison between receiver operating characteristic curves revealed that the DECAF score is significantly superior to the PEARL score (p = 0.04) in discriminating patients in need of ventilatory support. DECAF score with a cutoff value of 1 presented the highest sensitivity and BAP65 score with a cutoff value of 2 presented the highest specificity in predicting ventilatory support need. Multivariable analysis revealed that gender played a significant role in COPD exacerbation outcome, and arterial pCO2 and RDW measurements were also predictors of ventilatory support need. Within severity indexes, only the DECAF score was independently associated with the outcome. One-point increase in DECAF score created a 1.43 times higher risk of ventilatory support need. All severity indexes showed a correlation with age, comorbidity index, and dyspnea. BAP65 and DECAF scores also showed a correlation with length of stay.Objective and practical classifications are needed by clinicians to assess prognosis and initiate treatment accordingly. DECAF score is a strong candidate among severity indexes.CONCLUSIONObjective and practical classifications are needed by clinicians to assess prognosis and initiate treatment accordingly. DECAF score is a strong candidate among severity indexes.
Prognostic models aid clinical practice with decision-making on treatment and hospitalization in exacerbation of chronic obstructive lung disease (ECOPD). Although there are many studies with prognostic models, diagnostic accuracy is variable within and between models. We compared the prognostic performance of the BAP65 score, DECAF score, PEARL score, and modified early warning score (MEWS) in hospitalized patients with ECOPD, to estimate ventilatory support need. This cross-sectional study consisted of 139 patients. Patients in need of noninvasive or invasive mechanical ventilation support are grouped as ventilatory support groups (n = 54). Comparison between receiver operating characteristic curves revealed that the DECAF score is significantly superior to the PEARL score (p = 0.04) in discriminating patients in need of ventilatory support. DECAF score with a cutoff value of 1 presented the highest sensitivity and BAP65 score with a cutoff value of 2 presented the highest specificity in predicting ventilatory support need. Multivariable analysis revealed that gender played a significant role in COPD exacerbation outcome, and arterial pCO2 and RDW measurements were also predictors of ventilatory support need. Within severity indexes, only the DECAF score was independently associated with the outcome. One-point increase in DECAF score created a 1.43 times higher risk of ventilatory support need. All severity indexes showed a correlation with age, comorbidity index, and dyspnea. BAP65 and DECAF scores also showed a correlation with length of stay. Objective and practical classifications are needed by clinicians to assess prognosis and initiate treatment accordingly. DECAF score is a strong candidate among severity indexes.
Objective: Prognostic models aid clinical practice with decision-making on treatment and hospitalization in exacerbation of chronic obstructive lung disease (ECOPD). Although there are many studies with prognostic models, diagnostic accuracy is variable within and between models. Subjects and Methods: We compared the prognostic performance of the BAP65 score, DECAF score, PEARL score, and modified early warning score (MEWS) in hospitalized patients with ECOPD, to estimate ventilatory support need. Results: This cross-sectional study consisted of 139 patients. Patients in need of noninvasive or invasive mechanical ventilation support are grouped as ventilatory support groups (n = 54). Comparison between receiver operating characteristic curves revealed that the DECAF score is significantly superior to the PEARL score (p = 0.04) in discriminating patients in need of ventilatory support. DECAF score with a cutoff value of 1 presented the highest sensitivity and BAP65 score with a cutoff value of 2 presented the highest specificity in predicting ventilatory support need. Multivariable analysis revealed that gender played a significant role in COPD exacerbation outcome, and arterial pCO2 and RDW measurements were also predictors of ventilatory support need. Within severity indexes, only the DECAF score was independently associated with the outcome. One-point increase in DECAF score created a 1.43 times higher risk of ventilatory support need. All severity indexes showed a correlation with age, comorbidity index, and dyspnea. BAP65 and DECAF scores also showed a correlation with length of stay. Conclusion: Objective and practical classifications are needed by clinicians to assess prognosis and initiate treatment accordingly. DECAF score is a strong candidate among severity indexes.
Abstract Objective: Prognostic models aid clinical practice with decision-making on treatment and hospitalization in exacerbation of chronic obstructive lung disease (ECOPD). Although there are many studies with prognostic models, diagnostic accuracy is variable within and between models. Subjects and Methods: We compared the prognostic performance of the BAP65 score, DECAF score, PEARL score, and modified early warning score (MEWS) in hospitalized patients with ECOPD, to estimate ventilatory support need. Results: This cross-sectional study consisted of 139 patients. Patients in need of noninvasive or invasive mechanical ventilation support are grouped as ventilatory support groups (n = 54). Comparison between receiver operating characteristic curves revealed that the DECAF score is significantly superior to the PEARL score (p = 0.04) in discriminating patients in need of ventilatory support. DECAF score with a cutoff value of 1 presented the highest sensitivity and BAP65 score with a cutoff value of 2 presented the highest specificity in predicting ventilatory support need. Multivariable analysis revealed that gender played a significant role in COPD exacerbation outcome, and arterial pCO2 and RDW measurements were also predictors of ventilatory support need. Within severity indexes, only the DECAF score was independently associated with the outcome. One-point increase in DECAF score created a 1.43 times higher risk of ventilatory support need. All severity indexes showed a correlation with age, comorbidity index, and dyspnea. BAP65 and DECAF scores also showed a correlation with length of stay. Conclusion: Objective and practical classifications are needed by clinicians to assess prognosis and initiate treatment accordingly. DECAF score is a strong candidate among severity indexes. Highlights of the StudyObjective and practical classifications are needed by clinicians in order to assess prognosis and initiate treatment accordingly in exacerbation of chronic obstructive lung disease.DECAF score with a cutoff value of 1 presented the highest sensitivity and BAP65 score with a cutoff value of 2 presented the highest specificity in predicting the need for ventilatory support.One-point increase in DECAF score created a 1.43 times higher risk of need for ventilatory support.
Patients with a waiting period in the emergency department for more than 72 h before admission or ICU admission before being admitted to the ward were also excluded from the study. Components of prognostic scores DECAF PEARL BAP-65 NEWS MEWS Dyspnea eMRCD score eMRCD score - - - Blood measurements Eosinophil count <0.05 × 109/L - Urea nitrogen ≥25 mg/dL - - Chest X-ray Consolidation - - - - Blood gas analysis pH <7.30 - - Oxygen saturation - Comorbidities Atrial fibrillation Right heart failure - - - Left heart failure Age - Age >80 Age >65 - - Previous exacerbation - Previous admission >2 - - - Vital signs and mental status - - Heart rate Systolic blood pressure Systolic blood pressure Heart rate Heart rate Respiratory rate Respiratory rate Altered mental status (GKS score) Temperature Temperature AVPU score AVPU score The BAP65 score was developed by Tabak et al. MEWS is validated in medical admissions [14] using systolic blood pressure, heart rate, respiratory rate, temperature, and AVPU score for consciousness. Clinical characteristics and laboratory measurements upon admission (n = 139) Age, years 68.1±8.9 Male gender, n (%) 120 (86.3) Smoking status, n (%)  Current smoker 24 (17.3)  Ex-smoker 87 (62.6)  Never smoker 11 (7.9) Smoking, pack/year 50.0 [30.0–70.0] Comorbidities, n (%)  CAD 30 (21.6)  HT 51 (36.7)  AF 9 (6.5)  HF 26 (18.8)  DM 28 (20.1)  CVD 6 (4.3)  CRF 16 (11.5)  Bronchiectasis 7 (5.0)  Malignancy 12 (8.6)  OSA 3 (2.2) Charlson comorbidity index 2.0 [1.0–4.0] Duration of COPD diagnosis, years 7.0 [3.0–10.0] All ECOPD episodes in the last year 2.0 [1.0–3.0]  Hospitalization in the last year 1.0 [0.0–1.7]  ED visit in the last year 2.5 [1.0–4.0] Home LTOT, n (%) 54 (38.8) eMRC 3.0 [2.0–4.0] Laboratory measurements  White blood cell count, 109/L 9.15 [6.86–12.98]  Eosinophil count, 106/L 68.5 [13.0–194.2]  RDW 13.3 [12.0–15.0]  BNP, ng/L 82.0 [36.2–385.0]  Albumin, g/L 34.8±5.2 Arterial blood gas analysis  pH 7.39±0.07  pO2, mm Hg 65.0 [50.4–82.7]  pCO2, mm Hg 47.0 [37.4–59.0]  HCO3, mmol/L 26.9 [24.0–30.8] CRP at admission, mg/L 13.4 [4.6–90.7] Procalcitonin at admission, µg/L 0.07 [0.03–0.23] Severity indexes  BAP 65 score 1.0 [1.0–2.0]   Class 1 20 (14.4)   Class 2 47 (33.8)   Class 3 34 (24.5)   Class 4 10 (7.2)   Class 5 1 (0.7)  PEARL score 2.0 [1.0–4.0]   Low risk, n (%) 52 (37.4)   Intermediate risk, n (%) 51 (36.7)   High risk, n (%) 20 (14.4)  DECAF score 1.0 [1.0–2.0]  MEWS
Author Aydin-Güçlü, Özge
Ursavaş, Ahmet
Yildiz, Merve Nur
Karadağ, Mehmet
Uzaslan, Esra
Acet-Öztürk, Nilüfer Aylin
Demirdöğen, Ezgi
Görek Dilektaşli, Aslı
Coşkun, Funda
Author_xml – sequence: 1
  givenname: Nilüfer Aylin
  surname: Acet-Öztürk
  fullname: Acet-Öztürk, Nilüfer Aylin
  email: *Nilüfer Aylin Acet-Öztürk, niluferacet@gmail.com
– sequence: 2
  givenname: Özge
  surname: Aydin-Güçlü
  fullname: Aydin-Güçlü, Özge
– sequence: 3
  givenname: Merve Nur
  surname: Yildiz
  fullname: Yildiz, Merve Nur
– sequence: 4
  givenname: Ezgi
  surname: Demirdöğen
  fullname: Demirdöğen, Ezgi
– sequence: 5
  givenname: Aslı
  surname: Görek Dilektaşli
  fullname: Görek Dilektaşli, Aslı
– sequence: 6
  givenname: Funda
  surname: Coşkun
  fullname: Coşkun, Funda
– sequence: 7
  givenname: Esra
  surname: Uzaslan
  fullname: Uzaslan, Esra
– sequence: 8
  givenname: Ahmet
  surname: Ursavaş
  fullname: Ursavaş, Ahmet
– sequence: 9
  givenname: Mehmet
  surname: Karadağ
  fullname: Karadağ, Mehmet
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38626747$$D View this record in MEDLINE/PubMed
BookMark eNpt0k1v1DAQBuAIFdEPOHBHyFIvIO2CHSe2c0JLuqVIWxp1QRwjx55s3e7awU4qyt_hj-IqJQLEybbm0Tu2PIfJnnUWkuQ5wW8IyYu3GOOcCkHSR8kByVI6xyQne3GPCZnznJP95DCE68gEpfhJsk8FSxnP-EHys3S7TnoTnEWuRe8XFctn6GRZLk5nqFouLlczJK1G58uva7RWzkNAxqLKgzaqN3aDLiF0xsve-Tu0HrrO-R59AtD37MzFWi-35kc8L79LBb6RvRl7lVfeWaPQRRN6P8SwW0CrISaemAAyAKoiBduHp8njVm4DPHtYj5Ivp8vP5dl8dfHhY7lYzVUmcD8v2jaXjGSFxiwjkjcSUi5zpRgXTDPGsBCt4LhgDQGhtRRNw2mqW61SoBroUfJuzO2GZgdaxd5ebuvOm530d7WTpv67Ys1VvXG3NSFpjnPMY8KrhwTvvg0Q-npngoLtVlpwQ6gpzjBNScZZpMf_0Gs3eBvfF1VB4zOKrIjq5Z9Xmu7y-wMjeD0C5V0IHtqJEFzfD0c9DUe0L0Z7I_0G_CSn8vF_y-dVNYq60y39BTIQwKI
Cites_doi 10.1016/j.rmed.2013.01.007
10.3111/13696998.2013.800525
10.1080/15412555.2021.1959540
10.1136/thoraxjnl-2016-209298
10.1111/crj.13028
10.1093/qjmed/94.10.521
10.1183/23120541.00436-2022
10.1136/bmj.l5358
10.1016/j.jcrc.2012.02.015
10.26355/eurrev_202106_26045
10.1111/crj.12973
10.1136/thoraxjnl-2017-211197
10.1136/thoraxjnl-2019-213470
10.1016/j.ejim.2018.10.018
10.1136/thoraxjnl-2012-202103
10.4266/kjccm.2013.28.4.255
10.1080/17476348.2021.1901584
10.1378/chest.10-3035
10.1183/13993003.02426-2016
10.1136/thoraxjnl-2015-207775
10.1136/thoraxjnl-2019-213788
10.1001/archinternmed.2009.270
ContentType Journal Article
Copyright 2024 The Author(s). Published by S. Karger AG, Basel
2024 The Author(s). Published by S. Karger AG, Basel.
2024 The Author(s). Published by S. Karger AG, Basel. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at: https://uk.sagepub.com/en-gb/eur/reusing-open-access-and-sage-choice-content
2024 The Author(s). Published by S. Karger AG, Basel 2024
Copyright_xml – notice: 2024 The Author(s). Published by S. Karger AG, Basel
– notice: 2024 The Author(s). Published by S. Karger AG, Basel.
– notice: 2024 The Author(s). Published by S. Karger AG, Basel. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at: https://uk.sagepub.com/en-gb/eur/reusing-open-access-and-sage-choice-content
– notice: 2024 The Author(s). Published by S. Karger AG, Basel 2024
DBID M--
AAYXX
CITATION
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1159/000538812
DatabaseName Karger Open Access Journals
CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One Community College
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed
CrossRef

ProQuest One Academic Middle East (New)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: M--
  name: Karger Open Access Journals
  url: https://www.karger.com/OpenAccess
  sourceTypes:
    Enrichment Source
    Publisher
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Comparison of BAP65, DECAF, PEARL, and MEWS Scores in COPD Exacerbation
EISSN 1423-0151
EndPage 363
ExternalDocumentID PMC11250507
38626747
10_1159_000538812
538812
Genre Journal Article
GroupedDBID ---
0R~
0~B
326
36B
3O.
4.4
53G
5GY
7X7
88E
8FI
8FJ
8UI
AAWTL
AAYIC
ABBTS
ABPAZ
ABUWG
ABWCG
ACGFS
ADBBV
AENEX
AEYAO
AFKRA
AHFRZ
AHMBA
ALDHI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZPMC
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
CS3
DIK
DU5
E0A
E3Z
EBS
EMB
EMOBN
F5P
FB.
FYUFA
GROUPED_DOAJ
HMCUK
HYE
HZ~
IAO
IHR
ITC
KUZGX
M--
M1P
MK0
O1H
O9-
OK1
P2P
PHGZT
PQQKQ
PROAC
PSQYO
RKO
RNS
RPM
SV3
UJ6
UKHRP
30W
AAYXX
ACQXL
ADAGL
AFJJK
AFSIO
AIOBO
CAG
CITATION
COF
CYUIP
EJD
PHGZM
RIG
RXVBD
TR2
NPM
PJZUB
PPXIY
3V.
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c480t-9ff5a6149d0641a7bae27a5cc6786d666088f87096b1e8dda8bb732dfdc2e3de3
IEDL.DBID 7X7
ISSN 1011-7571
1423-0151
IngestDate Thu Aug 21 18:33:54 EDT 2025
Fri Jul 11 00:54:01 EDT 2025
Wed Aug 13 06:41:48 EDT 2025
Mon Jul 21 06:04:20 EDT 2025
Tue Jul 01 04:55:31 EDT 2025
Fri Apr 25 05:07:09 EDT 2025
Fri Apr 25 05:07:44 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Chronic obstructive lung disease exacerbation
Hospitalization
Severity indexes
Respiratory support
Language English
License This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission.
https://creativecommons.org/licenses/by-nc/4.0
2024 The Author(s). Published by S. Karger AG, Basel.
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c480t-9ff5a6149d0641a7bae27a5cc6786d666088f87096b1e8dda8bb732dfdc2e3de3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://karger.com/doi/10.1159/000538812
PMID 38626747
PQID 3093149949
PQPubID 2047984
PageCount 9
ParticipantIDs proquest_miscellaneous_3040321476
crossref_primary_10_1159_000538812
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11250507
karger_primary_538812
pubmed_primary_38626747
proquest_journals_3093149949
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-04-16
PublicationDateYYYYMMDD 2024-04-16
PublicationDate_xml – month: 04
  year: 2024
  text: 2024-04-16
  day: 16
PublicationDecade 2020
PublicationPlace Basel, Switzerland
PublicationPlace_xml – name: Basel, Switzerland
– name: Switzerland
– name: Basel
PublicationTitle Medical principles and practice
PublicationTitleAlternate Med Princ Pract
PublicationYear 2024
Publisher S. Karger AG
Publisher_xml – name: S. Karger AG
References Tabak YP, Sun X, Johannes RS, Gupta V, Shorr AF. Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score. Arch Intern Med. 2009;169(17):1595–602.
Lane ND, Gillespie SM, Steer J, Bourke SC. Uptake of clinical prognostic tools in COPD exacerbations requiring hospitalisation. COPD. 2021;18(4):406–10.
Unal A, Bayram B, Ergan B, Can K, Ergun YK, Kilinc O. Comparison of two scores for short-term outcomes in patients with COPD exacerbation in the emergency department: the Ottawa COPD Risk Scale and the DECAF score. ERJ Open Res. 2023;9(2):00436–2022.
Son JH, Lee JY, Yang YM, Sung WY, Seo SW, Kim JC, . Utility of the DECAF score in patients admitted to emergency department with acute exacerbation of chronic obstructive pulmonary disease. Korean J Crit Care Med. 2013;28(4):255–65.
Germini F, Veronese G, Marcucci M, Coen D, Ardemagni D, Montano N, . Validation of the BAP-65 score for prediction of in-hospital death or use of mechanical ventilation in patients presenting to the emergency department with an acute exacerbation of COPD: a retrospective multi-center study from the Italian Society of Emergency Medicine (SIMEU). Eur J Intern Med. 2019;61:62–8.
Vogelmeier C, Chair, Agusti A, Anzueto A, Barnes P, Bourbeau J, . The global strategy for diagnosis, management and prevention of COPD (GOLD) 2023 report. https://goldcopd.org/2023-gold-report-2/Date (last accessed August 30, 2023).
Bellou V, Belbasis L, Konstantinidis AK, Tzoulaki I, Evangelou E. Prognostic models for outcome prediction in patients with chronic obstructive pulmonary disease: systematic review and critical appraisal. BMJ. 2019;367:l5358.
Shorr AF, Sun X, Johannes RS, Yaitanes A, Tabak YP. Validation of a novel risk score for severity of illness in acute exacerbations of COPD. Chest. 2011;140(5):1177–83.
Shafuddin E, Chang CL, Hancox RJ. Comparing severity scores in exacerbations of chronic obstructive pulmonary disease. Clin Respir J. 2018;12(12):2668–75.
de Miguel-Díez J, Jiménez-García R, Hernández-Barrera V, Puente-Maestu L, Rodríguez-Rodríguez P, López de Andrés A, . Trends in hospital admissions for acute exacerbation of COPD in Spain from 2006 to 2010. Respir Med. 2013;107(5):717–23.
Suh ES, Sage B. COPD exacerbations: 2 much NEWS. Thorax. 2019;74(10):929–30.
Echevarria C, Steer J, Heslop-Marshall K, Stenton SC, Hickey PM, Hughes R, . The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD. Thorax. 2017;72(8):686–93.
Shorr AF, Sun X, Johannes RS, Derby KG, Tabak YP. Predicting the need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: comparing the CURB-65 and BAP-65 scores. J Crit Care. 2012;27(6):564–70.
Rochwerg B, Brochard L, Elliott MW, Hess D, Hill NS, Nava S, . Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J. 2017;50(2):1602426.
Steer J, Gibson J, Bourke SC. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax. 2012;67(11):970–6.
Echevarria C, Gray J, Hartley T, Steer J, Miller J, Simpson AJ, . Home treatment of COPD exacerbation selected by DECAF score: a non-inferiority, randomised controlled trial and economic evaluation. Thorax. 2018;73(8):713–22.
Shen MH, Qiu GQ, Wu XM, Dong MJ. Utility of the DECAF score for predicting survival of patients with COPD: a meta-analysis of diagnostic accuracy studies. Eur Rev Med Pharmacol Sci. 2021;25(11):4037–50.
Gayaf M, Karadeniz G, Güldaval F, Polat G, Türk M. Which one is superior in predicting 30 and 90 days mortality after COPD exacerbation: DECAF, CURB-65, PSI, BAP-65, PLR, NLR. Expert Rev Respir Med. 2021;15(6):845–51.
Echevarria C, Steer J, Heslop-Marshall K, Stenton SC, Hickey PM, Hughes R, . Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD. Thorax. 2016;71(2):133–40.
Johannesdottir SA, Christiansen CF, Johansen MB, Olsen M, Xu X, Parker JM, . Hospitalization with acute exacerbation of chronic obstructive pulmonary disease and associated health resource utilization: a population-based Danish cohort study. J Med Econ. 2013;16(7):897–906.
Shi QF, Sheng Y, Zhu N, Tan Y, Xie XH, Wang SY, . The v-DECAF score can predict 90-day all-cause mortality in patients with COPD exacerbation requiring invasive mechanical ventilation. Clin Respir J. 2019;13(7):438–45.
Subbe CP, Kruger M, Rutherford P, Gemmel L. Validation of a modified early warning score in medical admissions. QJM. 2001;94(10):521–6.
Echevarria C, Steer J, Bourke SC. Comparison of early warning scores in patients with COPD exacerbation: DECAF and NEWS score. Thorax. 2019;74(10):941–6.
ref13
ref12
ref15
ref14
ref20
ref11
ref22
ref10
ref21
ref2
ref1
ref17
ref16
ref19
ref18
ref8
ref7
ref9
ref4
ref3
ref6
ref5
References_xml – reference: Rochwerg B, Brochard L, Elliott MW, Hess D, Hill NS, Nava S, . Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J. 2017;50(2):1602426.
– reference: Lane ND, Gillespie SM, Steer J, Bourke SC. Uptake of clinical prognostic tools in COPD exacerbations requiring hospitalisation. COPD. 2021;18(4):406–10.
– reference: Suh ES, Sage B. COPD exacerbations: 2 much NEWS. Thorax. 2019;74(10):929–30.
– reference: Vogelmeier C, Chair, Agusti A, Anzueto A, Barnes P, Bourbeau J, . The global strategy for diagnosis, management and prevention of COPD (GOLD) 2023 report. https://goldcopd.org/2023-gold-report-2/Date (last accessed August 30, 2023).
– reference: Shorr AF, Sun X, Johannes RS, Derby KG, Tabak YP. Predicting the need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: comparing the CURB-65 and BAP-65 scores. J Crit Care. 2012;27(6):564–70.
– reference: Shorr AF, Sun X, Johannes RS, Yaitanes A, Tabak YP. Validation of a novel risk score for severity of illness in acute exacerbations of COPD. Chest. 2011;140(5):1177–83.
– reference: Shi QF, Sheng Y, Zhu N, Tan Y, Xie XH, Wang SY, . The v-DECAF score can predict 90-day all-cause mortality in patients with COPD exacerbation requiring invasive mechanical ventilation. Clin Respir J. 2019;13(7):438–45.
– reference: Echevarria C, Steer J, Heslop-Marshall K, Stenton SC, Hickey PM, Hughes R, . The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD. Thorax. 2017;72(8):686–93.
– reference: Gayaf M, Karadeniz G, Güldaval F, Polat G, Türk M. Which one is superior in predicting 30 and 90 days mortality after COPD exacerbation: DECAF, CURB-65, PSI, BAP-65, PLR, NLR. Expert Rev Respir Med. 2021;15(6):845–51.
– reference: Germini F, Veronese G, Marcucci M, Coen D, Ardemagni D, Montano N, . Validation of the BAP-65 score for prediction of in-hospital death or use of mechanical ventilation in patients presenting to the emergency department with an acute exacerbation of COPD: a retrospective multi-center study from the Italian Society of Emergency Medicine (SIMEU). Eur J Intern Med. 2019;61:62–8.
– reference: Echevarria C, Steer J, Bourke SC. Comparison of early warning scores in patients with COPD exacerbation: DECAF and NEWS score. Thorax. 2019;74(10):941–6.
– reference: Tabak YP, Sun X, Johannes RS, Gupta V, Shorr AF. Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score. Arch Intern Med. 2009;169(17):1595–602.
– reference: Shafuddin E, Chang CL, Hancox RJ. Comparing severity scores in exacerbations of chronic obstructive pulmonary disease. Clin Respir J. 2018;12(12):2668–75.
– reference: Johannesdottir SA, Christiansen CF, Johansen MB, Olsen M, Xu X, Parker JM, . Hospitalization with acute exacerbation of chronic obstructive pulmonary disease and associated health resource utilization: a population-based Danish cohort study. J Med Econ. 2013;16(7):897–906.
– reference: Echevarria C, Gray J, Hartley T, Steer J, Miller J, Simpson AJ, . Home treatment of COPD exacerbation selected by DECAF score: a non-inferiority, randomised controlled trial and economic evaluation. Thorax. 2018;73(8):713–22.
– reference: Unal A, Bayram B, Ergan B, Can K, Ergun YK, Kilinc O. Comparison of two scores for short-term outcomes in patients with COPD exacerbation in the emergency department: the Ottawa COPD Risk Scale and the DECAF score. ERJ Open Res. 2023;9(2):00436–2022.
– reference: de Miguel-Díez J, Jiménez-García R, Hernández-Barrera V, Puente-Maestu L, Rodríguez-Rodríguez P, López de Andrés A, . Trends in hospital admissions for acute exacerbation of COPD in Spain from 2006 to 2010. Respir Med. 2013;107(5):717–23.
– reference: Steer J, Gibson J, Bourke SC. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax. 2012;67(11):970–6.
– reference: Subbe CP, Kruger M, Rutherford P, Gemmel L. Validation of a modified early warning score in medical admissions. QJM. 2001;94(10):521–6.
– reference: Shen MH, Qiu GQ, Wu XM, Dong MJ. Utility of the DECAF score for predicting survival of patients with COPD: a meta-analysis of diagnostic accuracy studies. Eur Rev Med Pharmacol Sci. 2021;25(11):4037–50.
– reference: Bellou V, Belbasis L, Konstantinidis AK, Tzoulaki I, Evangelou E. Prognostic models for outcome prediction in patients with chronic obstructive pulmonary disease: systematic review and critical appraisal. BMJ. 2019;367:l5358.
– reference: Son JH, Lee JY, Yang YM, Sung WY, Seo SW, Kim JC, . Utility of the DECAF score in patients admitted to emergency department with acute exacerbation of chronic obstructive pulmonary disease. Korean J Crit Care Med. 2013;28(4):255–65.
– reference: Echevarria C, Steer J, Heslop-Marshall K, Stenton SC, Hickey PM, Hughes R, . Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD. Thorax. 2016;71(2):133–40.
– ident: ref2
  doi: 10.1016/j.rmed.2013.01.007
– ident: ref1
  doi: 10.3111/13696998.2013.800525
– ident: ref14
  doi: 10.1080/15412555.2021.1959540
– ident: ref11
  doi: 10.1136/thoraxjnl-2016-209298
– ident: ref10
  doi: 10.1111/crj.13028
– ident: ref13
  doi: 10.1093/qjmed/94.10.521
– ident: ref17
  doi: 10.1183/23120541.00436-2022
– ident: ref3
  doi: 10.1136/bmj.l5358
– ident: ref21
  doi: 10.1016/j.jcrc.2012.02.015
– ident: ref20
  doi: 10.26355/eurrev_202106_26045
– ident: ref19
  doi: 10.1111/crj.12973
– ident: ref16
  doi: 10.1136/thoraxjnl-2017-211197
– ident: ref15
  doi: 10.1136/thoraxjnl-2019-213470
– ident: ref7
  doi: 10.1016/j.ejim.2018.10.018
– ident: ref8
  doi: 10.1136/thoraxjnl-2012-202103
– ident: ref22
  doi: 10.4266/kjccm.2013.28.4.255
– ident: ref18
  doi: 10.1080/17476348.2021.1901584
– ident: ref6
  doi: 10.1378/chest.10-3035
– ident: ref4
  doi: 10.1183/13993003.02426-2016
– ident: ref9
  doi: 10.1136/thoraxjnl-2015-207775
– ident: ref12
  doi: 10.1136/thoraxjnl-2019-213788
– ident: ref5
  doi: 10.1001/archinternmed.2009.270
SSID ssj0008330
Score 2.3258784
Snippet Abstract Objective: Prognostic models aid clinical practice with decision-making on treatment and hospitalization in exacerbation of chronic obstructive lung...
Objective: Prognostic models aid clinical practice with decision-making on treatment and hospitalization in exacerbation of chronic obstructive lung disease...
Prognostic models aid clinical practice with decision-making on treatment and hospitalization in exacerbation of chronic obstructive lung disease (ECOPD)....
Patients with a waiting period in the emergency department for more than 72 h before admission or ICU admission before being admitted to the ward were also...
SourceID pubmedcentral
proquest
pubmed
crossref
karger
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 355
SubjectTerms Age
Blood pressure
Cardiac arrhythmia
Chronic obstructive pulmonary disease
Clinical medicine
Comorbidity
Consciousness
Dyspnea
Emergency medical care
Heart failure
Heart rate
Hospitalization
Intensive care
Lung diseases
Mortality
Original Paper
Oxygen saturation
Patients
Risk factors
Statistical analysis
Steroids
Variables
Ventilators
SummonAdditionalLinks – databaseName: Karger Open Access Journals
  dbid: M--
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Nb9QwELVQQVUviI8CgYIGxHEtJbETx8dlm1WFmhK1VPQWObGjrpCyFdtWiL_DH2UmTkK3gmPiL1nP9rzJOG8Y-6idaSMha26tTLhstOF15BSPkTugiy1tK-lv5OIkPTqXny-Si-F7B_0L853uP_fSqJO2ABrcPvWcyDJKJ_wQ_ShBKvkF59OZmwnhdQeiiKtERYOG0FbTPbYriL8rSqVyxwg98mP-i2Levyl5x_Qsn7DHA2eEuQf5KXvgumdstxii4s_Z78WUTBDWLXyal2kyg8N8MV_OoMznp8czMJ2FIv92BmekW7mBVQflD-qBrj3D6d-AO1CeT-TkcIJ2jaqNmUVWv_A5_2kaBKKHk8YatHXhSz0I0d46OMbzAw594AdKr9u62Wfny_zr4ogPyRd4I7Pwmuu2TQzabm2RtERG1cbFyiRNg9Yttej04PHU4mbXKWKbWWuyulYitq1tYiesEy_YTrfu3CsGsWgSaY3EfqxMQ2EkenE6VaGjxsYG7MOIRnXlNTaq3jdJdDWhF7B9j9NUZXx_cO99UZa-qLqyLRaPqFbD7txUFP3FmWmpA_Z-KsZ9RcES07n1DdWRYZ_EKQ3YS78IphHGZRSwbGt5TBVIs3u7pFtd9trdSG-Rc4bq9X-m84btxUibKF4VpQdsB7Fzb5H2XNfv-hX_B3yP-04
  priority: 102
  providerName: Karger AG
Title Comparison of BAP65, DECAF, PEARL, and MEWS Scores in Predicting Respiratory Support Need in Hospitalized Exacerbation of Chronic Obstructive Lung Disease Patients
URI https://karger.com/doi/10.1159/000538812
https://www.ncbi.nlm.nih.gov/pubmed/38626747
https://www.proquest.com/docview/3093149949
https://www.proquest.com/docview/3040321476
https://pubmed.ncbi.nlm.nih.gov/PMC11250507
Volume 33
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1db9MwFLVgQ4gXxMcYGaMyiMdaJLETx0-o61JNaClRx0TfIid2RIWUlnVMiL_DH-XexMnohHiJlNj5kI7te67vzbmEvFNW1wEXJTNGRExUSrMysJKFwB3AxRamFvg3cjaPzy7Fx2W0dBtuW5dW2a-J7UJt1hXukb_HiB2weSXUh813hlWjMLrqSmjcJ_soXYYpXXI5OFzALninRhAETEYycMpCYMHbWnY8SYJwxx49-Ibp11f_Ypt3kyb_skKzJ-Sxo4900uH9lNyzzTPyMHMB8ufk93SoK0jXNT2Z5HE0pqfpdDIb0zydLM7HVDeGZumXC3qBEpZbumpofoVPwAxouriNvVMs-Qn0nM7BxGG3vsjI6hecpz91BZi0yOK7nMwu_VQ6TdobS89hKaGnXQyI5p2E6_aAXM7Sz9Mz5uowsEok_jVTdR1pMOPKAH8JtCy1DaWOqgoMXWzA_4GVqoZ5r2KAOTFGJ2UpeWhqU4WWG8tfkL1m3diXhIa8ioTRAp5jROxzLcChU7H0Ld6sjUfe9mgUm05uo2jdlEgVA2QeOehwGrr014_vXM_yvGsqNqaG5h7Vwk3UbXE7rDzyZmiGKYZxE93Y9Q_sI_y2nlPskcNuEAxv4OgRgkvmkWRneAwdUL57t6VZfW1lvIHpAv305dH_v-sVeRQCkcIIVhAfkz2A0L4GInRdjtrRPiL7J-k8X4za7QQ4Zoz9AQdKCjc
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VFAEXxKOAocCA4BYL27t-HRBKE0cpjYOVtqI3s_auRYTkhKY8_w53fiOzfpVUiFuP8W7WlubbmW88628AXoRKFDbjmSkld02eh8LMbOWbDnEHSrG5LLj-GjmeeZNj_vbEPdmC3-23MPpYZesTK0ctl7l-R_5KV-yIzYc8fLP6bOquUbq62rbQqGFxoH58o5Rt_Xp_RPZ96Tjj6Gg4MZuuAmbOA-vMDIvCFRSUQknR2BZ-JpTjCzfPyW17ktg87buCUBx69NCBlCLIMp85spC5o5hUjNa9AtucUSrTg-29aJbMO98fMFbrH9i26bu-3WgZEWeouuexILCdjQh49ZM-8H36L3578ZjmX3FvfAtuNoQVBzXCbsOWKu_Atbgpyd-FX8OukyEuC9wbJJ7bx1E0HIz7mESD-bSPopQYR-8P8VCLZq5xUWJyqlfQZ65xfl7tR91klBICnFFQ1dPatiaLn_Q7-i5yQkGFJX2vRtgX32WNCu5XhVNyXjiqq06Y1KKx6x04vhQb3YNeuSzVA0CH5S6XgtM6knsWE5xSyNDzLaX_LKQBz1trpKta4COtEiM3TDuTGbBT26mb0l7fvXA9TpJ6KF3JgoZbq6aNa1in50A24Fk3TJtaV2pEqZZf9BxuVR2kPAPu1yDo7sB0DkpJoAHBBjy6CVowfHOkXHyshMOJWxPhtfyH_3-up3B9chRP0-n-7OAR3HCIxun6me3tQo_MqR4TDTvLnjTYR_hw2dvtD1-HRjU
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VgqpeEI8ChgILglus2t611z4gFBJHLU2C1VKRm1l712qE5ISmPP8O_4Jfx4xfJRXi1mO8m3WieX3jGX8D8CIyqnC5yGythW-LPFJ25hppe4gdMMUWuhD0NvJkGuyfiLczf7YBv9t3YaitsvWJlaPWi5yeke9RxQ7RfCSivaJpi0iGo9fLzzZNkKJKaztOo1aRQ_PjG6Zvq1cHQ5T1S88bxe8H-3YzYcDOReic21FR-AoDVKQxMrtKZsp4Uvl5ji480Ijs0QYL1OgowD8Qaq3CLJPc04XOPcO14XjuNbguue-SjclZl-whsuE1E4Lr2tKXbsNqhOihmqPHw9D11mLhjU_U-n32L6R7uWHzrwg4ugU3G-jK-rWu3YYNU96BrUlTnL8LvwbdTEO2KNibfhL4PTaMB_1RjyVx_2jcY6rUbBJ_OGbHRJ-5YvOSJWd0AnVfs6OLuj-jcaOYGrAphlfa1g44mf_Ez_F3laM-VFpF92ooftm7rOHD_WrYGN0YG9b1J5bU9LGrHTi5Egndg81yUZoHwDye-0IrgedoEThcCUwmo0A6hr6stAXPW2mky5rqI61SJD9KO5FZsFPLqdvSXt-9dH2SJPVSutQFLrdSTRsnsUovVNqCZ90ymjfVbFRpFl9oj3CqWVKBBfdrJejuwCkbxXTQgnBNPboNRB2-vlLOTysKcUTZCH0d-fD_v-spbKGRpeOD6eEj2PYQz1EhzQ12YROlaR4jHjvPnlSKz-DjVVvaH-lfSQU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+BAP65%2C+DECAF%2C+PEARL%2C+and+MEWS+Scores+in+Predicting+Respiratory+Support+Need+in+Hospitalized+Exacerbation+of+Chronic+Obstructive+Lung+Disease+Patients&rft.jtitle=Medical+principles+and+practice&rft.au=Acet-%C3%96zt%C3%BCrk%2C+Nil%C3%BCfer+Aylin&rft.au=Aydin-G%C3%BC%C3%A7l%C3%BC%2C+%C3%96zge&rft.au=Yildiz%2C+Merve+Nur&rft.au=Demird%C3%B6%C4%9Fen%2C+Ezgi&rft.date=2024-04-16&rft.issn=1423-0151&rft.eissn=1423-0151&rft.spage=1&rft_id=info:doi/10.1159%2F000538812&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1011-7571&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1011-7571&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1011-7571&client=summon